Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

October 23, 2020
BioUtah COVID-19 Analysis COVID-19 Updates Featured Members Federal News Life Sciences Industry News Policy News
Sanofi Commits $1M to Support Parkinson’s Disease Genetic Research

Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic testing and counseling for people with Parkinson’s disease in the U.S. Over the next two years, Sanofi will provide $1 million in research funding to support the PD GENEration Mapping the Future of Parkinson’s Disease initiative. The […]

October 16, 2020
COVID-19 Legislation COVID-19 Updates Federal News Policy News
SBA Extends PPP Loan Deferral, New Streamlined Forgiveness for Loans of $50,000 or Less

On October 7, the SBA released updated FAQs (question #52) to clarify that lenders must recognize the extended deferral period for payments on the principal, interest, and fees on all PPP loans, even if the initial loan terms indicates a six-month deferral (the initial period when the program was first enacted). Under the Paycheck Protection […]

October 16, 2020
BioUtah News COVID-19 Updates Life Sciences Industry News Press Releases State News Utah's Life Sciences Companies
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections

Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]

October 16, 2020
BioUtah News Featured Members Life Sciences Industry News State News Utah's Life Sciences Companies
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors.  “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]

October 16, 2020
BioUtah News Business Tools & Resources COVID-19 Updates State News Utah's Life Sciences Companies
Governor Herbert Announces New COVID-19 Transmission Index

On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan utilizes a COVID-19 Transmission Index and replaces the previous color-coded guidance system of red, orange, yellow and green. The new approach comes at a time when the state has seen a significant spike in infection rates. The […]

October 14, 2020
BioUtah News Industry News Life Sciences Industry News
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors 

CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that the first patient has been dosed with TP-1454, an investigational small-molecule pyruvate kinase M2 isoform (PKM2) activator, administered alone and in combination with ipilimumab and nivolumab, in a Phase 1/1b study in patients with advanced […]

October 9, 2020
Federal News Industry News Policy News
Pediatric Rare Disease Voucher Program Extended

Congress recently provided a short-term extension until December 11 of the Rare Pediatric Disease Priority Review Voucher program. The program was set to expire on September 30, but was given a reprieve in the Continuing Appropriations Act, 2021 and Other Extensions Act (H.R. 8337) that kept the government funded. Congress will have to act again […]

October 9, 2020
BioUtah News State News Utah's Life Sciences Companies
SINTX Technologies Develops New Mask Fabric with Silicon Nitride

On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory viruses. SINTX has successfully embedded silicon nitride particles into nonwoven and woven fabric fibers. Silicon nitride has been shown to neutralize several bacterial species and viral strains, including SARS-CoV-2.  “By investing in our human resources and equipment, […]

October 9, 2020
BioUtah News Funding Industry News Life Sciences Industry News Utah's Life Sciences Companies
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor

Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical device company that has developed the XenoscopeTM, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed to be fog proof, the Xenoscope minimizes common visualization challenges and provides consistent image quality through electrocautery smoke. MPVF’s […]

October 9, 2020
COVID-19 Updates Industry News
Johnson & Johnson Signs Communiqué on Expanded Global Access for COVID-19

Johnson & Johnson recently announced that it’s joined 15 other companies in signing a Communiquie on Expanded Global Access to ensure that people everywhere – regardless of their income level – have access to COVID-19 vaccines, therapeutics and diagnostics under development at these companies.  Each of the signing companies—AstraZeneca; Bayer; bioMérieux; Boehringer Ingelheim; Bristol Myers […]

October 9, 2020
BioUtah News State News Utah's Life Sciences Companies
U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology

U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center. This new centralized office builds on the work by the Center for Technology & Venture Commercialization (TVC) and will facilitate the U’s efforts to drive technology commercialization and economic […]

October 9, 2020
Industry News Life Sciences Industry News
Xenocor Granted Breakthrough Technology Agreement with Premier Inc.

Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY, October 5, 2020–– Xenocor, Inc. offering the world’s first disposable articulating laparoscope, has received a group purchasing agreement with Premier Inc. for their single use Xenoscope™, in the surgical disposable scope category. The Xenocor disposable laparoscopic system […]